Source: CNNMoney.com
Posted: February 12, 2008: 12:05 PM EST
CNNMoney.com reports Geron Corporation, a biotechnology company in the field of embryonic stem cell research, is preparing to begin embryonic stem cell studies humans with spinal cord injuries, pending FDA approval:
"The first experiments using human embryonic stem cells in human subjects could begin within a few months, the chief executive of biotech Geron said Monday. At the annual BIO CEO conference in New York, Dr. Thomas Okarma said Geron plans to start embryonic stem-cell studies in humans with spinal cord injuries toward the end of the second quarter. Okarma said the tests would involve up to 40 human patients, while all prior tests involved rats."
